Publication: Clinical Study of the Ginko biloba - Troxerutin-Heptaminol Hce in the Treatment of Acute Hemorrhoidal Attacks
Issued Date
2004-02-01
Resource Type
ISSN
01252208
Other identifier(s)
2-s2.0-1842710947
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.87, No.2 (2004), 137-142
Suggested Citation
Kanit Sumboonnanonda, Panuwat Lertsithichai Clinical Study of the Ginko biloba - Troxerutin-Heptaminol Hce in the Treatment of Acute Hemorrhoidal Attacks. Journal of the Medical Association of Thailand. Vol.87, No.2 (2004), 137-142. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/21735
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Clinical Study of the Ginko biloba - Troxerutin-Heptaminol Hce in the Treatment of Acute Hemorrhoidal Attacks
Author(s)
Other Contributor(s)
Abstract
Objective: The aim of this study was to assess the clinical efficacy, compliance and safety of Ginko biloba - Troxerutin-Heptaminol Hce in the treatment of patients with acute hemorrhoidal attacks in Thailand. Material and Method: In a prospective clinical study on hospital outpatients, the authors studied the effect of Ginko biloba - Troxerutin-Heptaminol Hce for a week in adults (18-70 years old) with acute hemorrhoidal attacks. Result: Twenty-two patients, with a mean age of 41.7 years were included in the study. The male to female ratio was 1:1.2. Most patients (77%) had grade 1 and 2 hemorrhoids with an average duration of attacks of 3 days. On intention to treat analysis, bleeding, pain, tenesmus and discharge were significantly improved. Treatment was well accepted and safe. Conclusion: In the short-term, Ginko biloba - Troxerutin-Heptaminol Hce is effective, acceptable and safe in the treatment of patients with acute hemorrhoidal attacks.